---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-009622"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T09:52:56.388213+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Samuel O'Rear to retire at 2024 annual meeting

## Summary
- Samuel O'Rear will not stand for reelection at the 2024 annual meeting.
- O'Rear's retirement is not due to any disagreement with the company.
- No replacement for the director position has been announced.

## SEC filing metadata
- accession: 0001213900-24-009622
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390024009622/0001213900-24-009622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390024009622/ea192567-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-009622
- JSON: https://secwatch.observer/filing/0001213900-24-009622.json
- Plain text: https://secwatch.observer/filing/0001213900-24-009622.txt

## Key facts
- Executive change
  Samuel O'Rear departed as Director at Sensus Healthcare, Inc..
  - Action: not stand for reelection
  - Role: Director
  source text: On January 30, 2024, Sensus Healthcare, Inc. (the “Company”) was advised by Samuel O’Rear, a director of the Company, of his intention not to stand for reelection to the Company’s Board of Directors (the “Board”) at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390024009622/0001213900-24-009622-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.